News
In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...
This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...
Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...
A new exploratory study will evaluate the safety of Anktiva in patients with long COVID, with secondary and exploratory ...
In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed articles of the week—featuring updated ...
In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...
Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...
In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...
In this episode of the Applied Clinical Trials Brief, we spotlight a recent video interview in which Jon Walsh, founder and ...
With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing ...
An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient ...
The Denali trial confirmed non-inferiority of NCX 470 to latanoprost in lowering intraocular pressure, with consistent efficacy, favorable safety, and supportive results from the earlier Mont Blanc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback